Loading interface...

Milixim CV (200/125 mg) Tablet

Manufactured byGLENMARK PHARMACEUTICALS LTD
ContainsCefixime (200 mg) + Clavulanic Acid (125 mg)
Description
Milixim CV (200/125 mg) Tablet is a combination medicine that consists of Cefixime and Clavulanic acid. It is used to treat a variety of conditions such as urinary tract infections, ear infections, and lung infections caused by bacteria. It works by killing or stopping the growth and multiplication of bacteria. It is not effective against infections caused by viruses. Milixim CV (200/125 mg) Tablet can cause side effects like nausea, vomiting, diarrhoea, etc. Seek medical attention if any of these side effects persist or worsen. Do not take this medicine if you are allergic to it. This medicine is not recommended for use in children less than 10 years of age. Milixim CV (200/125 mg) Tablet can be taken with or without food. Take this medicine same time every day. Be sure to complete the course as directed by your doctor in order to avoid bacterial resistance to this medicine. It may decrease the effectiveness of birth control pills and the cholera vaccine. Hence, inform your doctor about your ongoing medicines. Milixim CV (200/125 mg) Tablet may not be suitable for all people. Inform your doctor if you have any liver, kidney or blood clotting/bleeding issues before taking this medicine. Inform your doctor if you are pregnant or breastfeeding mother before starting therapy with Milixim CV (200/125 mg) Tablet as it may not be safe for use.

Side effects

Major & minor side effects for Milixim CV (200/125 mg) Tablet

  • Diarrhoea
  • Abdominal pain
  • Dark or clay colored stools
  • Swelling of face, lips, eyelids, tongue, hands and feet
  • Dizziness
  • Acid or sour stomach
  • Excessive air or gas in stomach
  • Heartburn
  • Indigestion
  • Redness of skin

Uses of Milixim CV (200/125 mg) Tablet

What is it prescribed for?

  • Uncomplicated urinary tract infections
  • Upper Respiratory Tract Infection
  • Tonsilitis/Pharyngitis
  • Acute exacerbations of chronic bronchitis
  • Gonococcal infection
  • Otitis media
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    The effect of Milixim CV (200/125 mg) Tablet can be observed within 2 to 4 hours after taking it.
  • How long do the effects of this medicine last?
    The amount of time for which Milixim CV (200/125 mg) Tablet remains active in the body is not known.
  • Is it safe to consume alcohol while taking this medicine?
    Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported for Milixim CV (200/125 mg) Tablet.
  • Can this medicine be taken during pregnancy?
    Milixim CV (200/125 mg) Tablet is not recommended to use in pregnancy as this medicine may affect the developing joints of your foetus. Your doctor may prescribe this medicine if the benefits outweigh the risks.
  • Can this medicine be taken while breast-feeding?
    Milixim CV (200/125 mg) Tablet is not recommended to use in breastfeeding as it may harm your infant. Consult your doctor. Your doctor may prescribe this medicine if the benefits outweigh the risks. If this medicine is used the baby should be observed for symptoms like diarrhoea or yeast infections.

Allergy

Avoid taking Milixim CV (200/125 mg) Tablet if you are allergic to it. Seek immediate medical attention if you notice any symptoms of allergic reactions such as skin rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, breathing difficulty, etc.
Warnings for special population

Pregnancy

Milixim CV (200/125 mg) Tablet is not recommended to use in pregnancy as this medicine may affect the developing joints of your foetus. Your doctor may prescribe this medicine if the benefits outweigh the risks.

Breast-feeding

Milixim CV (200/125 mg) Tablet is not recommended to use in breastfeeding as it may harm your infant. Consult your doctor. Your doctor may prescribe this medicine if the benefits outweigh the risks. If this medicine is used the baby should be observed for symptoms like diarrhoea or yeast infections.
General warnings

Clostridium difficile-associated Diarrhoea

Milixim CV (200/125 mg) Tablet may also kill the helpful bacteria in your stomach or intestine. This leads to an overgrowth of the Clostridium bacteria which releases a toxin that causes severe diarrhoea. Seek medical help if you experience severe diarrhoea that is watery or bloody. Consult your pharmacist/doctor before taking anti-diarrhoeal medication.

Bleeding disorders

Milixim CV (200/125 mg) Tablet should be used with caution if you have bleeding disorders due to the increased risk of excessive bleeding. Regular monitoring of prothrombin time is necessary in such cases. Your doctor may adjust the dose of this medicine if required.

Antibiotic resistance

Finish your entire course of treatment with Milixim CV (200/125 mg) Tablet, even if the condition gets better to avoid antibiotic resistance (the bacteria may become resistant to antibiotics). If you still feel unwell after completing your antibiotic course, consult your doctor.

Missed Dose

Take the missed dose of Milixim CV (200/125 mg) Tablet as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Never take more than the prescribed dose of Milixim CV (200/125 mg) Tablet. Seek emergency medical treatment or contact your doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.

Instructions

Interaction with alcohol is unknown. It is advisable to consult your doctor before consumption.
Interaction with Medicine

Amikacin

Chloramphenicol

Nifedipine

Warfarin

Ethinyl Estradiol

Cholera Vaccine

Furosemide

Disease interactions

Colitis

Colitis is the inflammation of the large intestine. Milixim CV (200/125 mg) Tablet can kill the helpful bacteria in your stomach or intestine and leads to diarrhoea. Therefore use this medicine with extreme caution if you have any stomach and intestinal diseases, particularly colitis, as it may worsen your health condition.

Kidney diseases

Milixim CV (200/125 mg) Tablet is filtered by the kidney and excreted through urine. Hence, maintain caution while using Milixim CV (200/125 mg) Tablet if you have any kidney disease as it can increase the risk of kidney damage.
Food interactions
Information not available.
Lab interactions

Coombs test

The Coombs' test is used to detect antibodies that act against the surface of your red blood cells. A false-positive result may be obtained if this test is performed while taking Milixim CV (200/125 mg) Tablet.

Urine ketones test

The test measures ketone levels in your urine. A false-positive result may be obtained if this test is performed while taking Milixim CV (200/125 mg) Tablet.
Take Milixim CV (200/125 mg) Tablet with or without food, as instructed by your doctor. Do not take more than the prescribed dose. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor. Keep away from the reach of children and pets. Do not use it after the expiry date. Ensure that unused medicine is disposed of properly. Do not give your medicine to other people even if their condition appears to be the same as yours.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

Does not cause sleepiness

How it works
Cefixime works by interfering with certain processes that help the bacteria to grow and increase in number. Clavulanic acid is effective against a specific species of bacteria that are resistant to other antibiotic medicines. Thus, the combination becomes effective against an extended range of bacteria.
Legal Status

Approved

Unknown

Unknown

Unknown

Classification

Category

Third generation cephalosporins, Beta-lactamase inhibitors

Schedule

Schedule H

Bionova.co.in. 2021. CEFDIS CV Tablet-Cefixime. [online] Available at: < [Accessed 31 August 2021].

http://www.bionova.co.in/cefdis-cv-tablet.html>

CiplaMed. 2021. OMNIX CV Tablets. [online] Available at: < [Accessed 31 August 2021].

https://ciplamed.com/content/omnix-cv-tablets-0>

Dailymed.nlm.nih.gov. 2021. These highlights do not include all the information needed to use SUPRAX safely and effectively. See full prescribing information for SUPRAX.Suprax (cefixime) Tablets USP, 400 mgSuprax (cefixime) Capsules, 400 mgSuprax (cefixime) Chewable Tablets, 100 mg, 150 mg and 200 mgSuprax (cefixime) for Oral Suspension USP, 100 mg/5 mLSuprax (cefixime) for Oral Suspension USP, 200 mg/5 mLSuprax (cefixime) for Oral Suspension USP, 500 mg/5 mLFor oral administrationInitial U.S. Approval:1986To reduce the development of drug-resistant bacteria and maintain the effectiveness of Suprax and other antibacterial drugs, Suprax should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.. [online] Available at: < [Accessed 31 August 2021].

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5007152e-a679-4e85-ac3f-c46087812774>

Medicines.org.uk. 2021. Suprax Tablets 200 mg - Summary of Product Characteristics (SmPC) - (emc). [online] Available at: < [Accessed 31 August 2021].

https://www.medicines.org.uk/emc/medicine/14540>

Drugs, H., 2021. Cefixime: MedlinePlus Drug Information. [online] Medlineplus.gov. Available at: < [Accessed 31 August 2021].

https://medlineplus.gov/druginfo/meds/a690007.html>
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 3 Sep 2021

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.